# OnCo record hmbd-001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/hmbd-001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "hmbd-001" ;
  schema:name "HMBD-001"@en ;
  schema:description "HMBD-001 is an experimental monoclonal antibody from Hummingbird Bioscience in phase 2 trials for non-small-cell lung cancer, head and neck squamous cell carcinoma and oesophageal cancer, aimed at HER3 and EGFR."@en ;
  schema:url <https://onco.cc/drugs/hmbd-001/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=HMBD-001> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/nasopharyngeal/> ;
  onco:targets <https://onco.cc/targets/her3/>, <https://onco.cc/targets/egfr/> ;
  onco:companies <https://onco.cc/companies/hummingbird-bioscience/> ;
  onco:trials <https://onco.cc/trials/nct05910827/> .